For many people, treatment for prostate cancer involves lowering or blocking testosterone, because testosterone fuels the cancer’s growth. In fact, reducing testosterone is the cornerstone of prostate cancer treatment and often part of long-term management.
This means that for someone who wishes to have feminising hormone therapy after prostate cancer, the process is not only possible but is perfectly safe. Suppressing testosterone for feminisation achieves the same goal as cancer treatment while supporting gender-affirming care.
Antiandrogens and oestrogen are quite safe, if not better, for people who have prostate cancer, and allow individuals to live authentically while maintaining health and stability.